Withdrawal of Registration Statement (rw)
June 14 2019 - 5:13AM
Edgar (US Regulatory)
PROVENTION
BIO, INC.
P.O.
Box 666
Oldwick,
New Jersey 08858
June
14, 2019
Securities
and Exchange Commission
Division
of Corporation Finance
100
F Street, N.E.
Washington,
D.C. 20549
Re:
|
Provention
Bio, Inc. (the “Company”)
Request to Withdraw Registration Statement on Form S-1
(and all exhibits) (SEC File No. 333-232055)
|
Ladies
and Gentlemen:
Pursuant
to Rule 477(a) under the Securities Act of 1933, as amended (the “Securities Act”), the Company hereby requests that
the Securities and Exchange Commission (the “Commission”) consent to the withdrawal, effective as of the date hereof
or at the earliest practicable date hereafter, of the Company’s registration statement on Form S-1 (File No. 333-232055),
filed with the Commission on June 10, 2019 and initially as a Draft Registration Statement on May 29, 2019 (such registration
statement and all exhibits, collectively, the “Registration Statement”).
The
Company is seeking withdrawal of the Registration Statement because it has determined at this time not to proceed with the transaction
due to market conditions. The Company believes that withdrawal of the Registration Statement is consistent with the public interest
and the protection of investors, as contemplated by Rule 477(a) under the Securities Act. Please note that the Registration Statement
was not declared effective by the Commission and no securities of the Company were sold pursuant to the Registration Statement.
The
Company respectfully requests, in accordance with Rule 457(p) under the Securities Act, that all fees paid to the Commission in
connection with the filing of the Registration Statement be credited to the Company’s account for future use.
In
accordance with Rule 477(c) under the Securities Act, the Company respectfully advises the Commission that it may undertake a
subsequent private offering in reliance on Rule 155(c) under the Securities Act, following the withdrawal of the Registration
Statement.
It
is our understanding that this application for withdrawal of the Registration Statement will be deemed granted as of the date
that it is filed with the Commission unless, within fifteen days after such date, the Company receives notice from the Commission
that this application will not be granted.
If
you have any questions regarding this application for withdrawal, please contact me at 732-685-4284 or our outside counsel, Steven
Skolnick of Lowenstein Sander LLP, at 973-597-2476.
|
Very truly yours,
|
|
|
|
|
PROVENTION BIO, INC.
|
|
|
|
|
By:
|
/s/
Andrew Drechsler
|
|
|
Andrew
Drechsler
|
|
|
Chief
Financial Officer
|
Provention Bio (NASDAQ:PRVB)
Historical Stock Chart
From Jun 2024 to Jul 2024
Provention Bio (NASDAQ:PRVB)
Historical Stock Chart
From Jul 2023 to Jul 2024